CML Workshop - Current Perspectives and Treatment Update - May 21 With Dr. Mauro and Dr. Jabbour

[Guest guest]

Go to

http://www.cancercare.org/get_help/tew_details.php?tew=leukemia_052110 to

sign up.

This Workshop will take place on...

Friday, May 21, 2010, 1:30 - 2:30 pm ET

Workshop Topics

* Overview of CML

* Current Standard of Care and New Treatment Approaches

* Adherence: The Importance of Taking Your Pills on Schedule

* Managing Side Effects

* How Clinical Trials Contribute to Treatment Options

* Communicating with Your Health Care Team

* Questions for Our Panel of Experts

Speakers

J. Mauro, MD

Associate Professor, Center for Hematologic Malignancies, Knight Cancer

Institute at Oregon Health and Science University

Elias Jabbour, MD

Assistant Professor, Department of Leukemia, Division of Cancer Medicine,

The University of Texas M.D. Cancer Center

Zavie

Zavie (age 71)

67 Shoreham Avenue

Ottawa, Canada, K2G 3X3

dxd AUG/99

INF OCT/99 to FEB/00, CHF

No meds FEB/00 to JAN/01

Gleevec since MAR/27/01 (400 mg)

CCR SEP/01. #102 in Zero Club

2.8 log reduction Sep/05

3.0 log reduction Jan/06

2.9 log reduction Feb/07

3.6 log reduction Apr/08

3.6 log reduction Sep/08

3.7 log reduction Jan/09

3.8 log reduction May/09

3.8 log reduction Aug/09

4.0 log reduction Dec/09

e-mail: zmiller@...

Tel: 613-726-1117

Fax: 613-482-4801

Cell: 613-282-0204